| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 11/06/2024 | 22:00 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 20/05/2024 | 21:34 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 15/05/2024 | 16:40 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 04/12/2023 | 14:30 | GlobeNewswire Inc. | Sunshine Biopharma Moves Principal Office to New York City | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 11/08/2023 | 14:30 | GlobeNewswire Inc. | Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600% | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 16/05/2023 | 15:58 | GlobeNewswire Inc. | Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 12/05/2023 | 14:00 | GlobeNewswire Inc. | Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 11/05/2023 | 15:00 | GlobeNewswire Inc. | Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100% | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 05/04/2023 | 14:00 | GlobeNewswire Inc. | Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate Update | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 28/02/2023 | 13:30 | GlobeNewswire Inc. | Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 10/02/2023 | 13:35 | GlobeNewswire Inc. | Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 19/01/2023 | 13:30 | GlobeNewswire Inc. | Sunshine Biopharma Announces Share Repurchase Program | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 20/12/2022 | 14:00 | GlobeNewswire Inc. | Sunshine Biopharma’s Annual Letter to Shareholders | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 16/11/2022 | 14:00 | GlobeNewswire Inc. | Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA Project | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 20/10/2022 | 14:00 | GlobeNewswire Inc. | Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 04/08/2022 | 14:00 | GlobeNewswire Inc. | Sunshine Biopharma Files Its Second Quarter Report With the SEC | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 28/07/2022 | 14:10 | GlobeNewswire Inc. | Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of Arizona | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 28/04/2022 | 22:50 | GlobeNewswire Inc. | Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-Market | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 26/04/2022 | 06:41 | GlobeNewswire Inc. | Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 25/04/2022 | 14:00 | GlobeNewswire Inc. | Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 05/04/2022 | 14:00 | GlobeNewswire Inc. | Sunshine Biopharma’s Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer Cells | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 14/03/2022 | 23:12 | GlobeNewswire Inc. | Sunshine Biopharma, Inc. Announces Closing of $8.0 Million Private Placement Priced At-the-Market | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 10/03/2022 | 15:17 | GlobeNewswire Inc. | Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-Market | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 25/02/2022 | 16:20 | InvestorsHub NewsWire | SUNSHINE BIOPHARMA EXPANDS ANTI-CORONAVIRUS DRUG DEVELOPMENT PROGRAM BY SIGNING A COLLABORATION AGREEMENT WITH THE UNIVERSITY OF ARIZONA | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 25/02/2022 | 14:00 | GlobeNewswire Inc. | Sunshine Biopharma Expands Anti-Coronavirus Drug Development Program By Signing A Collaboration Agreement With The University Of Arizona | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 17/02/2022 | 16:07 | GlobeNewswire Inc. | Sunshine Biopharma, Inc. Announces Closing of $8 Million Public Offering and Uplisting to the Nasdaq Capital Market | NASDAQ:SBFMW | Sunshine Biopharma Inc |
| 15/02/2022 | 15:00 | GlobeNewswire Inc. | Sunshine Biopharma, Inc. Announces Pricing of $8 Million Public Offering and Uplisting to the Nasdaq Capital Market | NASDAQ:SBFMW | Sunshine Biopharma Inc |